Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...
Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
It's a brand-new year, and with that comes a tonne of new music for your lugholes. Let's see what the first New Music Friday of 2026 has to offer, shall we? Global girl group KATSEYE kick off the New ...
Chart does not reflect overnight price.
Is MPLX the next big buy? Chart does not reflect overnight price.
A high-level overview of MPLX LP Common Units (MPLX) stock. View (MPLX) real-time stock price, chart, news, analysis, analyst reviews and more.
Aaron Huizenga looks back at the propane industry’s 2025 and is looking ahead at what’s to come in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results